Product
  • Product
  • Supplier
  • Inquiry
    Home > News >

    Pharmaceutical

    banner
    A panoramic analysis of traditional Chinese medicine injection

    A panoramic analysis of traditional Chinese medicine injection

    In China's drug market, besides chemicals, there are also proprietary Chinese medicines with Chinese characteristics.
    medicine injection

    2019-08-16

    FDA approved olapanib for first-line treatment of ovarian cancer

    FDA approved olapanib for first-line treatment of ovarian cancer

    PMLiVE reported on December 19 that AstraZeneca's Lynparza became the first PARP inhibitor approved for the first-line maintenance treatment of BRCA mutated ovarian cancer.
    ovarian cancer

    2019-08-16

    The project of psychological care for the elderly will cover the whole country.

    The project of psychological care for the elderly will cover the whole country.

    At present, the elderly people are confronted by the elderly. The phenomenon of low awareness of mental health problems is widespread in China.
    elderly care

    2019-08-12

    The price of vitamins is very different, but the effect is the same?

    The price of vitamins is very different, but the effect is the same?

    Many people will advise you to eat more vitamin C when you have a cold. In many people's eyes, vitamins are closely related to health. But when we buy vitamins in drugstores, we will find an interesting phenomenon.
    Vitamin-C

    2019-08-09

    Focuses on Innovative Drugs and Responses to Market Change

    Focuses on Innovative Drugs and Responses to Market Change

    On July 29, Pfizer announced that it would merge Puqiang, its patent expiration brand and generic business unit, with the generic giant Mailan to create a new global pharmaceutical company.
    drugs

    2019-08-09

    How to cultivate large varieties of Chinese herbal pieces?

    How to cultivate large varieties of Chinese herbal pieces?

    According to traditional Chinese medicine on July 31, Chinese medicines have been processed to meet the requirements of the theory and application of Chinese medicinal properties.
    herbal

    2019-08-08

    "Three Chains Fusion" of Zhuhai Biomedical Industry

    According to the economic data of the first half of the year, Zhuhai's pillar industries realized 41.668 billion yuan in industrial added value, an increase of 5.0%.
    Biomedical Industry

    2019-08-08

    Adjusting the price of rituximab injection produced by Shanghai Fuhong Hanlin

    Adjusting the price of rituximab injection produced by Shanghai Fuhong Hanlin

    Shanghai Fuhong Hanlin Biopharmaceutical Co., Ltd. submitted an application for adjusting the purchase price of rituximab injection (100mg/10ml).
    rituximab injection

    2019-08-08

    How should domestic enterprises meet the development of generic medicine

    How should domestic enterprises meet the development of generic medicine

    After experiencing the pains of transformation, upgrading and structural adjustment, the generic pharmaceutical industry in China is entering a new stage of development.
    generic medicine

    2019-08-05

    the reason why foreign pharmaceutical enterprises sell out-of-date patents

    the reason why foreign pharmaceutical enterprises sell out-of-date patents

    According to internal information, the newly established Pfizer Upjohn expired patent product line has been confirmed for sale. Pfizer is the first foreign-owned enterprise to set up its global management team in China.
    pharmaceutical patent

    2019-08-05

    How the Medical Insurance Treatment Affects the Pharmaceutical Market

    How the Medical Insurance Treatment Affects the Pharmaceutical Market

    From the point of view of drug payment standard, the price determined by 4+7 collection and collection can be regarded as the national standard of medical insurance payment in the future.
    Medical insurance

    2019-08-02

    Suggestions
    Email:
    Message:
    Send Message